Concepedia

Baojin Zhu

BZ

Statistics

Publications

64

Citations

4.1K

H-Index

33

Active since

1995

Affiliations

Eli Lilly (United States)(Current)

Oregon Medical Research Center

University of Cincinnati

IBM (United States)

Assistance Publique – Hôpitaux de Paris

Baojin Zhu is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and psoriatic disease.

ORCID

Publications per year

1995–2022

64

Publications

64

Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care

Haya Ascher‐Svanum, Douglas E. Faries, Baojin Zhu et al. · The Journal of Clinical Psychiatry · 2006 · 488 citations

, , +17

The burden of depressive symptoms in the long-term treatment of patients with schizophrenia

R. Conley, Haya Ascher‐Svanum, Baojin Zhu et al. · Schizophrenia Research · 2006 · 294 citations · Full text

, , +14

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

Haya Ascher‐Svanum, Baojin Zhu, Douglas E. Faries et al. · BMC Psychiatry · 2010 · 280 citations · Full text

, , +14

Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus—the Hopkins Lupus Cohort

S. Al Sawah, Xiang Zhang, Baojin Zhu et al. · Lupus Science & Medicine · 2015 · 216 citations · Full text

, , +13

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Douglas E. Faries, Haya Ascher‐Svanum, Baojin Zhu et al. · BMC Psychiatry · 2005 · 183 citations · Full text

, , +17

1–5 of 64